Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
RAPT Therapeutics ( (RAPT) ) has issued an announcement.
RAPT Therapeutics has approved a repricing of underwater options for its employees, significantly reducing the exercise price to $1.57 per share, effective November 13, 2024. This move aims to retain and motivate employees without incurring stock dilution or additional cash compensation, as the options were previously priced between $8.18 and $44.66, far above the current market price. Employees must stay with the company through a specified retention period to benefit from the reduced exercise price.
See more data about RAPT stock on TipRanks’ Stock Analysis page.
